Floatz logo

Sitagliptin

Inflammation

University of Southern CaliforniaSmall moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
81/ 100

Competitive context

30 Active assets in the Inflammation cohort.

Asset / SponsorPhaseRating
Vildagliptin
Rio de Janeiro State University
Phase 4BB
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA
Taipei Veterans General Hospital, Taiwan
Phase 4BB
PITAVASTATIN
Aichi Gakuin University
Phase 4BB
SUFENTANYL
The First Affiliated Hospital with Nanjing Medical University
Phase 4BB
Pioglitazone
National Institute on Aging (NIA)
Phase 4B

View all 50 →

Same molecule, other indications

Sitagliptin is also rated in:

diabetes mellitusDormant
BBB
Indicative ·
73 / 100
View asset →
polycystic ovary syndromeDormant
BB
Indicative ·
70 / 100
View asset →
prediabetes syndromeDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →